Application 065441
- Type
- ANDA
- Sponsor
- ACS DOBFAR
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFEPIME HYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | No |
| 002 | CEFEPIME HYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065441-001 | CEFEPIME HYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | |
| A065441-002 | CEFEPIME HYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A065441-001 | AP |
| A065441-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A065441-001 | CEFEPIME HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A065441-002 | CEFEPIME HYDROCHLORIDE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2008-03-20 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A065441-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065441-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065441-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065441-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065441-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065441-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065441-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065441-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065441-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065441-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065441-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065441-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065441-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065441-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065441-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065441-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065441-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065441-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065441-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065441-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065441-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065441-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065441-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065441-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065441-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065441-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A065441-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A065441-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065441-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065441-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A065441-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A065441-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A065441-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A065441-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A065441-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A065441-002 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A065441-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A065441-002 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A065441-001 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A065441-002 | AP | 1 | 782e0a99824c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefepime | CEFEPIME | WG Critical Care, LLC | 5fd857e5-591f-44ca-80cf-fd903660b03c | 2026-06-23 | Warnings, Adverse reactions | 065441 ANDA065441 44567-241 44567-240 |
| Cefepime | CEFEPIME | WG Critical Care, LLC | c654ef2e-1067-4026-8931-6a0dc2a17ad1 | 2026-06-23 | Warnings, Adverse reactions | 065441 ANDA065441 44567-130 44567-131 |
| Cefepime | CEFEPIME | Hospira, Inc. | e80c27e2-164d-4836-ba24-c160d75dc5d3 | 2024-11-06 | Warnings, Adverse reactions | 065441 ANDA065441 0409-9566 0409-9735 |
| Cefepime | CEFEPIME | Fresenius Kabi USA, LLC | 5e1695e0-1310-4cd8-a5da-ad1a7dcd1792 | 2023-09-30 | Warnings, Adverse reactions | 065441 ANDA065441 63323-326 63323-340 |
| cefepime | CEFEPIME HYDROCHLORIDE | Sagent Pharmaceuticals | de477f37-40f6-4295-ae72-a2ee36a8922e | 2021-09-29 | Warnings, Adverse reactions | 065441 ANDA065441 25021-121 25021-122 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0409-9566 | Cefepime | Cefepime | Hospira, Inc. | ANDA | Current |
| 0409-9566 | Cefepime | Cefepime | Hospira, Inc. | ANDA | Current |
| 0409-9735 | Cefepime | Cefepime | Hospira, Inc. | ANDA | Current |
| 0409-9735 | Cefepime | Cefepime | Hospira, Inc. | ANDA | Current |
| 0781-3222 | Cefepime Hydrochloride | Cefepime Hydrochloride | Sandoz Inc | ANDA | Current |
| 0781-3223 | Cefepime Hydrochloride | Cefepime Hydrochloride | Sandoz Inc | ANDA | Current |
| 25021-121 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-121 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-121 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-121 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-121 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-121 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-121 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-121 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-122 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-122 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-122 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-122 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-122 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-122 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-122 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 25021-122 | cefepime | cefepime hydrochloride | Sagent Pharmaceuticals | ANDA | Current |
| 44567-130 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-130 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-131 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-131 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-240 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-240 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-240 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-240 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-240 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-240 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-241 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-241 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-241 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-241 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-241 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 44567-241 | Cefepime | Cefepime | WG Critical Care, LLC | ANDA | Current |
| 63323-326 | Cefepime | Cefepime | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-340 | Cefepime | Cefepime | Fresenius Kabi USA, LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 44240 | ORIG | 2008-03-21 |